Galectin Therapeutics, Inc. (NASDAQ: GALT) today announced that the Company has received a Notice of Allowance from the Australian Government ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE